About
Westfield BioVentures builds and backs biotech therapeutics ventures.
Venture Platform
Venture creation, intelligence, and investment aligned around biotech therapeutics.
Westfield BioVentures is focused on early-stage biotech therapeutics venture creation, incubation, acceleration, and investment. We work selectively with founders, scientific innovators, asset owners, and venture partners where our active involvement can help transform promising science into fundable and executable companies.
Our model is closely connected to VentriLinks, an AI-powered biotech innovation infrastructure platform. Through VentriLinks Opportunity Intelligence and VentriLinks Opportunity Activation, selected opportunities can be identified, evaluated, routed, and advanced into venture creation, investment, commercialization, licensing, or strategic partnering pathways.
WBV’s role is to help turn selected opportunities into structured, investable, and executable biotech ventures.
Platform Structure
Intelligence-driven opportunity activation and venture execution.
Opportunity Intelligence
Opportunity Evaluation
Activation Pathways
WBV Venture Execution
VentriLinks → Opportunity Intelligence → Opportunity Activation → WBV Execution
Principles
Selective venture-building guided by aligned execution.
Focus on early-stage biotech therapeutics
Build where active involvement can create value
Use intelligence to improve opportunity selection
Work with aligned investors and execution partners
Reserve operational support for companies we create, incubate, accelerate, or invest in
Seek equity-aligned value creation, not transactional consulting
Structured venture creation for differentiated biotech therapeutics opportunities.
WBV operates selectively where scientific innovation, opportunity intelligence, strategic capital, and coordinated execution intersect.
Contact Us